-
Huang Guo meets with Singaporean health authority CEO
2026-05-15
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met in Beijing on May 11 with a delegation led by Raymond Chua Swee Boon, chief executive officer of the Health Sciences Authority (HSA) of Singapore.
-
NMPA holds special training program on quality improvement of vaccines, blood products
2026-04-17
On April 10, the National Medical Products Administration (NMPA) convened a special public training program, with online and on-site participation, on inspection, rectification and quality improvement of vaccines and blood products in order to further reinforce oversight of the quality and safety of these medical products.
-
Yang Sheng meets with associate commissioner for global policy and strategy of US FDA
2026-02-03
On Jan 27, Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA) of China, met with a visiting delegation led by Mark Abdoo, associate commissioner for global regulatory operations and policy of the US Food and Drug Administration (FDA).
-
China revises drug administration regulations to spur innovation, tighten oversight
2026-01-28
China has revised regulations concerning drug administration in a bid to promote drug innovation, strengthen management of online sales of medicines and reinforce drug safety supervision.
-
NMPA to enhance drug regulation under revised rules — committed to a people-centered healthy policy and strengthen high-effect regulation
2026-01-08
The revised Regulation aims to further encourage drug research and innovation, strengthen the whole life-cycle control of drugs and provide a solid legal guarantee for high-level drug safety and the high-quality development of the pharmaceutical industry.
-
Revision and Release of the Good Manufacturing Practice for Medical Devices
2025-12-24
On November 4, the National Medical Products Administration (NMPA) released the revised version of the Good Manufacturing Practice for Medical Devices (hereinafter referred to as the GMP). The new GMP for medical devices shall come into effect as of November 1, 2026.
